SEC Filing Summary: AspenBio Pharma, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio Pharma, Inc. on November 17, 2006. The registrant is incorporated in Colorado. The filing serves to disclose the issuance of a press release regarding the company's results of operations and financial condition, as well as Regulation FD disclosure.
Note: The request metadata references "Riot Platforms, Inc.", but the provided filing text explicitly identifies the registrant as "AspenBio Pharma, Inc." This summary reflects the content of the provided text.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that a press release containing these details was issued on the date of the report. The specific financial data is contained in Exhibit 99.1, which is not included in the provided text.
Material Changes
The filing indicates that the company reported results of operations and financial condition via a press release. No specific material changes, percentage growth, or comparative figures against prior periods are detailed within the body of this 8-K form.
Guidance, Outlook, and Risks
The filing references a press release (Exhibit 99.1) for details on operations and financial condition. The text of the 8-K itself does not contain management commentary, future guidance, specific risk factors, or descriptions of unusual items.
Investor Verification Checklist
- Verify the content of the press release dated November 17, 2006 (Exhibit 99.1) for actual financial figures.
- Confirm the specific results of operations and financial condition disclosed in the referenced press release.
- Check for any subsequent filings that may provide updated financial data or context for the November 2006 period.